REGN
Regeneron Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$66.98B
P/E Ratio
15.60
EPS
$40.95
Beta
0.30
52W High
$818.90
52W Low
$473.89
50-Day MA
$729.49
200-Day MA
$693.36
Dividend Yield
0.56%
Profit Margin
29.60%
Forward P/E
14.24
PEG Ratio
1.11
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Fundamentals
| Revenue (TTM) | $14.92B |
| Gross Profit (TTM) | $6.55B |
| EBITDA | $4.38B |
| Operating Margin | 20.70% |
| Return on Equity | 14.50% |
| Return on Assets | 6.13% |
| Revenue/Share (TTM) | $143.56 |
| Book Value | $308.32 |
| Price-to-Book | 2.13 |
| Price-to-Sales (TTM) | 4.49 |
| EV/Revenue | 4.084 |
| EV/EBITDA | 10.61 |
| Quarterly Earnings Growth (YoY) | -7.20% |
| Quarterly Revenue Growth (YoY) | 19.00% |
| Shares Outstanding | $103.02M |
| Float | $97.67M |
| % Insiders | 2.03% |
| % Institutions | 92.13% |
Historical Volatility
HV 10-Day
56.50%
HV 20-Day
48.91%
HV 30-Day
41.53%
HV 60-Day
35.64%
HV Rank
77.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($833.31 target)
4
Strong Buy18
Buy7
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026